Epstein Barr Virus External Quality Assessment

The RIQAS Epstein Barr Virus EQA programme is designed to monitor the performance of tests used to detect EBV virus antibodies. All samples are conveniently supplied liquid ready-to-use and are suitable for both quantitative and qualitative methods of analysis.

  • Liquid ready-to-use
  • 100% human Plasma
  • Quarterly reporting (3 samples per quarterly distribution)
  • Submit results and view reports online via RIQASNet
  • Suitable for both quantitative and qualitative methods of analysis
Cat No Kit Size Frequency Cycle Start Analytes
RQ9153 Expand 3 x 1ml
(samples shipped 4 times
per year)
Quarterly reporting
(1 x 12 month cycle)
June 3

Analytes

  • Anti-EBNA IgG
  • Anti-EBV VCA IgG
  • Anti-EBV VCA IgM